Naster wants to raise over PLN 2.6 million as part of equity crowdfunding, and also plans to debut on NewConnect in mid-2023, the company said. Subscriptions for Naster shares started on October 11, 2022.
“Naster's strategy assumes a long-term approach to the renewable energy market. We made the decision to enter the stock exchange 5 years ago. We were guided by the long-term assumption that we want to obtain financing for the development of farms and green energy supplies for business customers, and not by fashion or increased demand for the sale of photovoltaics. In the meantime, we developed the sales, technical and customer service team. The pandemic has frustrated our plans a bit. However, we effectively and scrupulously pursue the goal once set. It should also be remembered that Naster's core business is energy contracting. Thanks to this, we not only better understand the market, but also we are able to survive various turmoil on the RES market. We have always focused the most on the business client, so the slowdown in the market is an opportunity for us to develop, ”said Maciej Sieracki, founder and CEO of Naster, quoted in the release.
As part of crowdfunding, Naster plans to collect PLN 2,600,000, most of which it wants to spend on the development of EaaS (Energy-as-a-Service) sales, heat pumps and photovoltaic (PV) installations for the B2B channel.
“Over the next 10 years, the growth of the RES market and the development of companies dealing with this subject will be visible. The current, temporary slowdown is an opportunity for Naster to grow dynamically, so we want to first obtain funding in crowdfunding, and then enter New Connect next year, ”added Sieracki.
The company plans to allocate PLN 600,000 from the obtained funds. PLN for investment in the development of EaS sales, 800 thousand. PLN for further development of sales of heat pumps, and 300 thousand. PLN for the development of sales of photovoltaic (PV) installations for the B2B channel, exchanged.
Source
You must be logged in to post a comment.